Podcasts about Abstract

What makes people trust you faster, remember your message longer, and say “yes” more often? Behavioral science has the answers. In this episode, AJ and Johnny sit down with behavioral science expert and author Richard Shotton to break down the psychological tactics behind persuasion, trust, and influence that anyone—not just brands—can use. From the power of concrete language to the pratfall effect, messenger bias, social proof, and scarcity hacks, Richard explains why these timeless psychological triggers work just as well in networking and sales as they do in billion-dollar marketing campaigns. Whether you're trying to stand out in a crowded room or get people to take action, these strategies are your edge. What to Listen For [00:00:00] Why ancient persuasion tactics still work today [00:00:53] Abstract vs. concrete language — why clarity wins [00:05:20] How Apple's “1000 songs in your pocket” made history [00:09:59] Why simple language makes you seem smarter [00:12:21] The pratfall effect — why flaws make you more likable [00:14:42] How to use the messenger effect to boost credibility [00:21:16] Social proof done right (and why most people get it wrong) [00:30:56] Scarcity and the pumpkin spice effect — why limits drive desire [00:36:23] Zeigarnik effect — the open loop that holds attention [00:51:40] Distinctiveness and the Liquid Death effect [00:55:42] How breaking small conventions signals status [00:57:05] Why giving people control boosts persuasion A Word From Our Sponsors Stop being over looked and unlock your X-Factor today at ⁠⁠⁠⁠⁠⁠unlockyourxfactor.com⁠⁠⁠⁠⁠⁠  The very qualities that make you exceptional in your field are working against you socially.  Visit the ⁠⁠⁠⁠⁠⁠artofcharm.com/intel ⁠⁠⁠⁠⁠⁠for a social intelligence assessment and discover exactly what's holding you back. Indulge in affordable luxury with Quince. Upgrade your wardrobe today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠quince.com/charm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for free shipping and hassle-free returns. Grow your way - with Headway! Get started at ⁠⁠⁠⁠⁠⁠makeheadway.com/CHARM ⁠⁠⁠⁠⁠⁠and use my code CHARM for 25% off. Ready to turn your business idea into reality? Sign up for your $1/month trial at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠shopify.com/charm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Need to hire top talent—fast? Claim your $75 Sponsored Job Credit now at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Indeed.com/charm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. This year, skip breaking a sweat AND breaking the bank. Get your summer savings and shop premium wireless plans at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠mintmobile.com/charm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Save more than fifty percent on term life insurance at ⁠⁠⁠⁠⁠⁠SELECTQUOTE.COM/CHARM⁠⁠⁠⁠⁠⁠ TODAY to get started  Curious about your influence level?  Get your Influence Index Score today! Take this 60-second quiz to find out how your influence stacks up against top performers at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠theartofcharm.com/influence⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Episode resources: Hacking the Human Mind: The behavioral science secrets Richard Shotton: Behavioural Science Check in with AJ and Johnny! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AJ on LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Johnny on LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AJ on Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Johnny on Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Art of Charm on Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Art of Charm on YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Art of Charm on TikTok Learn more about your ad choices. Visit megaphone.fm/adchoices

It's another “everything goes” abstract topic on TrekRanks as our expert panel tackles “Abstract L,” labeling luminous locations and lightships of all sorts that randomly begin with the letter L. This is TrekRanks at its abstract finest! Led by host Jim Moorhouse and guests Alex Perry, Claire Little and Ken Reilly, literally anything is on the table in this fun “flash ranks” episode recorded live at STLV via a temporal anomaly. Log in and let's fly! Episode Rundown: Diagnostic Cycle: We briefly go through not only our “Abstract” roll call, but our “Flash Ranks” roll call to prep for the topic. Prime Directive: Each guest on this week's panel reveals exactly how they narrowed down their list and made their final choices. The Order of Things: All the picks are revealed with the TrekRanks' original “Five words and a hashtag” summary, along with one episode that helps frame their choice. Secondary Systems: For a few extra picks that just missed our final list. Regeneration Cycle: The panel recaps their picks and we dissect some of the interesting statistical anomalies that arose from the discussion. Temporal Inversion: We flashback to a previous episode of TrekRanks and relay some of the feedback received from listeners. If you have your own picks you would like to relay to us, please hail us at 757-828-RANK (7265) and record your own personal TrekRanks log to let us know your picks for Abstract L. (Or you can record it yourself and just DM us @TrekRanks.com on Bluesky.) Your comments could be used as part of a Temporal Causality Loop on an upcoming episode (and might get you a chance to be a guest on a future episode, too). And don't forget to check out TrekRanks.com for our entire back catalog of episodes and a detailed rundown on every episode of Star Trek ever.

Featuring an interview with Dr Kevin Kalinsky, including the following topics: Prophylaxis, Monitoring and Management of Adverse Events of Special Interest with Datopotamab Deruxtecan (0:00) Lisberg A et al. Datopotamab deruxtecan-associated select adverse events: Clinical practices and institutional protocols on prophylaxis, monitoring, and management. Oncologist 2025;30(9). Abstract  Meric-Bernstam F et al. Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis. Oncologist 2025;30(3). Abstract   Clinical Data with Neoadjuvant Datopotamab Deruxtecan from the I-SPY 2.2 Phase II Trial (5:17) Khoury K et al. Datopotamab–deruxtecan in early-stage breast cancer: The sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med 2024;30(12):3728-36. Abstract  Shatsky RA et al. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: The sequential multiple assignment randomized I-SPY2.2 Phase II trial. Nat Med 2024;30(12):3737-47. Abstract  NeoSTAR: A Phase II Study of Response-Guided Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Localized Triple-Negative Breast Cancer (9:09) Abelman RO et al. A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. ASCO 2025;Abstract 511.  OptimICE-RD: A Phase III Study Evaluating Sacituzumab Govitecan with Pembrolizumab versus Pembrolizumab with or without Capecitabine for Residual Triple-Negative Breast Cancer (12:56) Tolaney SM et al. OptimICE-RD: Sacituzumab govitecan + pembrolizumab vs pembrolizumab (± capecitabine) for residual triple-negative breast cancer. Future Oncol 2024;20(31):2343-55. Abstract  CME information and select publications

Featuring an interview with Dr Aaron Lisberg, including the following topics: Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) for Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC): A Pooled Analysis of the TROPION-Lung01 and TROPION-Lung05 Trials (0:00) Ahn M-J et al. Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05. ESMO Asia 2024;Abstract LBA7 Ahn M-J et al. A pooled analysis of datopotamab deruxtecan in patients with EGFR-mutated NSCLC. J Thorac Oncol 2025;[Online ahead of print]. Abstract Sacituzumab Tirumotecan for Previously Treated Advanced EGFR-Mutated NSCLC: Results from the Randomized OptiTROP-Lung03 Study (7:08) Fang W et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: Multicentre, open label, randomised controlled trial. BMJ 2025;389:e085680. Abstract Zhang L et al. Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated advanced EGFR-mutated non-small cell lung cancer (NSCLC): Results from the randomized OptiTROP-Lung03 study. ASCO 2025;Abstract 8507. Combination of Dato-DXd and Immunotherapy as First-Line Therapy for Patients with Advanced NSCLC (13:12) Cuppens K et al. First-line (1L) datopotamab deruxtecan (Dato-DXd) + durvalumab ± carboplatin in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohorts 2 and 4). ESMO Targeted Anticancer Therapies Congress 2025;Abstract 8O. Okamoto I et al. TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer. Future Oncol 2024;20(37):2927-36. Abstract Levy BP et al. TROPION-Lung08: Phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC. Future Oncol 2023;19(21):1461-72. Abstract Aggarwal C et al. AVANZAR: Phase III study of datopotamab deruxtecan (Dato-DXd) + durvalumab + carboplatin as 1L treatment of advanced/mNSCLC. World Conference on Lung Cancer (WCLC) 2023;Abstract P2.04-02. TROP2-Targeting Antibody-Drug Conjugates as Neoadjuvant and/or Adjuvant Therapy for Patients with Resectable NSCLC (19:08) A phase III, randomised, open-label, global study of adjuvant datopotamab deruxtecan (Dato-DXd) in combination with rilvegostomig or rilvegostomig monotherapy versus standard of care, following complete tumour resection, in participants with Stage I adenocarcinoma non-small cell lung cancer who are ctDNA-positive or have high-risk pathological features (TROPION-Lung12). NCT06564844 Cascone T et al. Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: The platform phase 2 NeoCOAST-2 trial. Nat Med 2025;31(8):2788-96. Abstract CME information and select publications

Dr. Monty Pal and Dr. Fumiko Chino discuss several of the top abstracts presented at the 2025 ASCO Quality Care Symposium, including research on federally funded clinical trials and financial reimbursement for trial participation. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I am your host, Dr. Monty Pal. I am a medical oncologist, professor, and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. Today, we are highlighting key abstracts that were presented at the 2025 ASCO Quality Care Symposium. I am delighted to be joined today by the chair of this year's meeting, Dr. Fumiko Chino. Dr. Chino is an associate professor in radiation oncology at MD Anderson Cancer Center with a research focus on access, affordability, and equity. She is also a consultant editor of JCO Oncology Practice and the host of the Put into Practice podcast. I have got to listen to that.  Dr. Chino, welcome, and thanks so much for being on the podcast today. Dr. Fumiko Chino: I am overjoyed to be here, and absolutely, you should take a listen. Dr. Monty Pal: Definitely. And FYI for listeners, our full disclosures are all available in the transcript of this episode, so do have a look if you are inclined. Now, we have really seen some fantastic advances in health services and quality and supportive care, digital health, and beyond. There are some great abstracts that were presented at this year's meeting. I have actually picked a couple that I am particularly interested in and that I believe you share my interest in as well.  So, the first is an abstract actually from my friends at SWOG (Abstract 94). So, this was a terrific abstract from Joe Unger and Michael LeBlanc and Dawn Hershman. And this, I think, really hits on a very, very key issue right now, which is the benefit of federally funded trials. Do you mind just kind of spelling out some of the observations from what I think is a really brilliant piece of work? Dr. Fumiko Chino: Absolutely, and I think Dr. Unger's work is really important for our current funding environment. I think that this research is really essential to do to show the role of federal sponsorship in the design and conduct of clinical trials. Because what they did was really look at a landscape analysis over the last 20 years looking at funding and were able to show quite clearly that federal funding really matters for advancing the science in cancer care. So what they showed was that the federal funding was more commonly essential for early-stage clinical trials, so those phase 1, phase 2 trials that really help advance the science. And that federal funding was really essential for multimodality drug combinations, combinations with drug and surgery, combinations with drug and radiation. Those trials were much more likely to be federal funded. And then the last thing is that they showed that the patients that are, I think, the largest at risk for gaps in care who really need the advancements in science that keep U.S. health care amazing and wonderful and world-leading, so the kids, the pediatric patients, the patients with rare cancers, and the patients actually that could benefit from de-escalation or right-sizing of treatment, they were also all more likely to have federal funding. So I think this research that was presented really shows that if, unfortunately, current status of restricted federal funding continues, that we are going to lose out in terms of the next generation of cancer cures, cancer de-escalations, and the type of combination treatments that make advancements in science. Dr. Monty Pal: Indeed. You know, I always point to Joe Unger's paper, and I think it is in JAMA Oncology, right, that showed life-years gained from NCI trials. It is such an important piece of work. I think this is a really nice complement to that, isn't it, to show the specific areas that otherwise would be, am I right in saying, kind of largely untouched? Dr. Fumiko Chino: I think you are right in that what we know from what industry will sponsor versus what the federal government will sponsor, that the federal government really helps make up the gap to really make those advancements that save lives, that lead to more birthdays, that advance our knowledge and our capacity for providing more cures and more successful futures for our patients. I always like pointing to the de-escalation research, which is, and this is not to dig pharma, but no pharmaceutical company is going to run a trial that says you can give less of their drug, right? It just does not make sense for the business end of the science. And so, thinking about how to right-size treatments, how to do more with less, that really is the purview of the federal government. Dr. Monty Pal: Absolutely. Absolutely.  I am going to shift gears here and bring up another abstract that I found to be quite intriguing, and this relates to reimbursement of expenses, et cetera, for clinical trials. This is an abstract from Courtney Williams and team. It brings to mind the importance, I think, of recognizing the hardships that patients take on by clinical trials, but I also would love for you to comment on that sort of fine line between reimbursement for expenses and then, you know, sort of undue enticement. It is a challenging balance there. But give me your reflections on this abstract. Dr. Fumiko Chino: Absolutely. You are speaking about Dr. Williams' Abstract 93 from the Alabama group, and Alabama actually has this incredible group of health services researchers which is, are doing really important work in this space. What this trial shows is that, you know, it is a small pilot study, it is 30-something patients that received some support primarily for their travel and additional expenses related to their clinical trial participation for breast cancer. It showed that the money helps, and I think what we all know is that it is expensive to participate in clinical trials. It requires additional visits. It often requires some significant travel burden for our patients, and I do not feel that money reimbursement for clinical trial expenses is an inducement. Nobody participates in a clinical trial to get the money for their gas, right? We know that our patients are making some pretty significant sacrifices in order to participate in clinical trials, and what this type of program does is just actually reimburse them for their outlaying of funds.  And I loved this trial because the patients were actually given $1,000 a month for the first 4 months of their trial participation, and what the study showed is that the patients were using it for things like travel-related food, for things like transportation, caregiver expenses, or even some of their out-of-pocket medical expenses like cost sharing or prescriptions. And that they said that overall, the reimbursement really made a difference in terms of their capacity for staying on the clinical trial. Because we know our clinical trials really are not able to enroll the full diversity of patients that often have a disease, and that the patients that are at biggest risk for a health care disparity or a gap in care are also the least likely to enroll in a clinical trial.  Programs like this are an essential part of showing how financial toxicity can be overcome with pretty straightforward assistance to patients to help reimburse them for the things that they are already taking out of their pocket, for parking costs, for that $10 soup that they buy at the cancer center, for those additional expenses that we are, unfortunately, putting on them. Dr. Monty Pal: Very well said. And you know, I have started to dabble in clinical trials looking at CAR T-cell therapies for kidney cancer, and I have to tell you, it is just insane the amount of cost that a patient would have to take on to comply with the stipulations for some of these novel therapies. We require that they stay within 30 minutes of the facility for 28 days, and unless we are compensating for some of that, I mean, how can one afford a hotel stay that is that long? I mean, it is just, it is unprecedented, and it would certainly provide a huge barrier to many patients who would otherwise enroll. Really well said. I also wanted to bring up another financially driven topic, and treating renal cell, again, I would say the vast majority, 90% plus of my patients in clinic are on oral drug therapies. And I cannot tell you how often a patient will show up in my practice and say, "Doc, I have got 15 days out of this 30-day prescription left. What do I do with it?" You know, or some come with pill bottles from a deceased loved one. And it is so frustrating to say, "Take it to the pharmacy and they will just get rid of it for you." But sounds like there is an abstract from Dr. Mackler, Abstract 102, that seems to address this topic quite well. Am I right? Dr. Fumiko Chino: Absolutely. This presentation, I was the most excited about seeing because this group, which helps run a cancer drug repository, theirs is called YesRx, presented their data from the last approximately two years of running this repository, and they were able to show incredible benefit for their patients in Michigan. And it is a really straightforward program. It is run by pharmacists. It has support from the legislation in Michigan. And what they were able to show is that they repurposed medications that would otherwise have been discarded. They delivered them directly to the oncologist, which then actually dispersed them to the patients. They helped 1,000 patients in less than two years. They saved them millions of dollars, over $15 million presented in the abstract. And it is just a win-win-win because I know that patients actually, and sometimes patient caregivers, they feel very sad to have spent a lot of money out of pocket for their medication, and then if they have a dose reduction or, obviously, you know, if the surviving spouse then has to get rid of their medication, just dispose of them, it is very disheartening. And this is a way of kind of reclaiming power for patients. So they were able to accept donations from all over the state of Michigan and then also help over 1,000 patients. And so, it is a phenomenal program. Dr. Monty Pal: Just wild when I came across the dollar amounts, right, that they were saving. It just, it seems like a place that, you know, we just have to look, as cancer centers, right, and really take this on. Just brilliant. On that same theme of cost savings and so forth, you know, I think there has been a lot of focus on what recent policies have done in the context of us having access to therapies and so forth. And one of the topics that has come up is the Inflation Reduction Act and how changes pertaining to the IRA have really played a role in one's ability to take on some of these expensive prescriptions. And I believe John Lin and colleagues tackled that issue in Abstract 97. Could you comment on that, Fumiko? Dr. Fumiko Chino: Absolutely. Dr. Lin is one of my colleagues here at MD Anderson, so I know him very well, and he has been doing really phenomenal work over the last several years with looking at drug affordability and access. And what his analysis shows is that for patients, after the Inflation Reduction Act's cap on out-of-pocket expenses, is that it really did show that out-of-pocket expenses decreased. So what the Inflation Reduction Act did is that it eliminated the 5% co-insurance and placed this $2,000 cap on out-of-pocket expenses. And what that led to for these patients that were not able to have the low-income subsidy is that there were lower costs, and that there was a lower rate of drug abandonment, meaning that the prescription was not refilled. There was also a lower rate of unfilled prescriptions as well. And I think that it shows that health policy really can improve access to care. I think the flip side of the fact that the IRA, this policy, really did seem to help people is that what his research showed is that actually, even with the benefits of this cap, is that actually it is still really high in terms of the rate of people who are not able to fill their prescriptions or that completely abandon them over time. And that unfortunately, even with this change, that over half of people without the low-income subsidy were potentially not getting the full benefit of their medications because they were not able to afford them. And so I think it really kind of highlights that we still need to do more work about making drugs affordable. Dr. Monty Pal: Indeed, indeed. And I mean, in a setting like this, I mean, I think it is important to recognize that $2,000 is a lot, it is a big chunk of change, right, for a lot of families in the U.S. What do you think of the prospect of, like, decreasing that cap? Is that something that from a policy standpoint you would be supportive of? Dr. Fumiko Chino: Well, so something that is a real option for patients on Medicare is there is something called the Medicare Prescription Payment Plan, and what it allows you to do is actually prorate the $2,000 over the whole year. And so instead of having to pay $2,000 as soon as you fill your prescription, because you are going to have, if you have an expensive medication, it is essentially you have to pay the $2,000 in January, right? It allows you to prorate it, so essentially $170 a month, and that comes to you as like a regular bill. And I think that as rolled out as part of the IRA is a really lovely way of thinking about how do we make these payments more stable over time, so it is not a huge hit sort of at the beginning of the year. And I think that alone actually can make a difference in terms of trying to help make sure that people can actually get their medications. Dr. Monty Pal: That is an excellent tip. Excellent tip.  We are going to shift gears entirely. We have been talking a lot about the dollars and cents of things and talk about an abstract from Sophia Smith and colleagues. So this is Abstract 550 at your meeting. And this hinged on a program of sorts to deal with post-traumatic stress disorder. We do not often think about PTSD in the vernacular for oncology patients, but indeed, I mean, it is something that they must face, especially in the context of long-term survivorship. Can you talk a little bit about Dr. Smith's abstract? Dr. Fumiko Chino: Absolutely. I love this work from Dr. Smith, who is at Duke. She worked with Dr. Applebaum, who was my old colleague at Memorial Sloan Kettering. And this group of researchers really is trying to figure out how to best support people into survivorship so that they can actually thrive. And their patient population for this work was actually people who received stem cell transplant, and they focused on people who had PTSD symptoms. And what they were able to show through this SMART design, which is essentially this serial, multiple randomized trial, so everyone got randomized upfront to either usual care or this app, so this digital app that actually helped coach people through cancer distress. And then for the people who were non-responders, they were then additionally randomized to either the app plus coaching or a therapist versus the cognitive behavioral therapy or CBT.  And what they were able to show is that, number one, anyone who had the app seemed like they did better than those who did not start the path with the app. But then the additional help of either the therapist or the coach or the CBT made additional benefit over time. And so, I think this shows a really nice stepped care, which is you can potentially have some right-sizing of treatments cost saving, if we sort of give everyone the app, which is, I think, overall pretty low cost. And that for the people who do not get the full benefit from the app, then you can think about these maybe more tailored approaches, the therapist, the coach, the CBT, but that some people actually just respond to the app. And I think it allows us to, again, right-size the care for our patients. And I think it is really innovative to think about how technology can help improve access to care in the setting of something like PTSD. Dr. Monty Pal: Brilliant summary. Brilliant summary.  Gosh, it looks like such an exciting meeting this year. Congratulations on a terrific program for the ASCO Quality Care Symposium. I know you played a huge role in developing it, and thanks for sharing your insights on the ASCO Daily News Podcast. Dr. Fumiko Chino: No, I really appreciate you having me. ASCO Quality is my favorite meeting of the year. You know, it is really a phenomenal meeting, and I am so excited for next year in Boston in 2026. Dr. Monty Pal: Awesome. And thanks to our listeners too. You are going to find links to all the abstracts that we discussed today in the transcript of this episode. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. More on today's speakers: Dr. Sumanta (Monty) Pal  @montypal Dr. Fumiko Chino @fumikochino Follow ASCO on social media: @ASCO on Twitter ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures of Potential Conflicts of Interest: Dr. Monty Pal:     Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Fumiko Chino:  Consulting or Advisory Role: Institute for Value Based Medicine Research Funding: Merck

Scared of “being cringe” on social media? Here's how to sell art on Instagram and attract real collectors.  Most artists avoid Instagram because they're afraid of being seen, of bragging, or of looking silly. But that fear is keeping your art hidden from the very people who want to buy it.  In this episode of the Honest Art® Podcast, I break down how to sell art on Instagram without feeling fake, forced, or like you have to learn a TikTok dance.  You'll learn: The surprising reason most artists avoid Instagram (and how to most past it) The “3 P's” formula that makes your feed irresistible to collectors How to write captions that inspire, educate, or entertain (instead of putting people to sleep) Why posting your sales isn't bragging, it's inspiring Your art deserves to be seen. Instagram is the free, powerful tool that makes it possible. It's time to bloom.  Make sure to subscribe to this podcast so you don't miss a thing! And don't forget to come hang with me on Instagram @jodie_king_.  Interested in being a guest on a future episode of Honest Art®? Email me at amy@jodieking.com! Resources mentioned: Give Jodie a follow on Instagram to see how she does it:  https://www.instagram.com/jodie_king_/ Let's sling some paint together in person!!: https://jodieking.com/workshop  Join The Honest Art® Society Community: https://www.jodiekingart.com/has Purchase An Artist's Guide to Instagram: https://jodieking.com/mini-courses  Studio Elite: https://www.jodiekingart.com/studioelite   Episode 108: An Inside Look At Art Consulting With Amy Sawtelle: https://jodieking.com/episode-108-an-inside-look-at-art-consulting-with-amy-sawtelle/  Episode Episode 112: The Art of Transformation: Stacy Solodkin's Inspiring Creative Journey: https://jodieking.com/episode-112-the-art-of-transformation-stacy-solodkins-inspiring-creative-journey/  Stacy Solodking Instagram: https://www.instagram.com/stacysolodkin/  Episode 39: Ana Stapleton: A Creative Force: https://jodieking.com/episode-39-ana-stapleton-a-creative-force/  Ana Stapleton Instagram: https://www.instagram.com/anastapletonart/  Have a question for Jodie? Ask it here: https://forms.gle/hxrVu4oL4PVCKwZm6  How are you liking the Honest Art® Podcast? Leave us a review on your favorite podcast platform and let us know!     Watch this full episode on my YouTube channel: https://www.youtube.com/playlist?list=PLMquJfuMsSg0fr46BRdia1cWd-81GThzF For a full list of show notes and links, check out my blog: www.jodieking.com/podcast 

This week the American figurative abstract painter and writer Sophie Kipner who primarily uses the blind contouring technique. Sophie was born in Santa Monica in 1982 into an artistically musical family; her English mother Lizzie was a singer and dancer, her Australian father Steve, a songwriter, musician and producer, her grandfather, a songwriter and producer, and her brother Harrison, also a songwriter, musician and producer. Sophie however was to take a different route with an early interest in art, particularly sketching and learning portraiture, which would carry her through to her professional career.  Her parents emphasized self expression as a learning tool, encouraging her creativity. While attending Viewpoint High School in Calabasas she developed an interest in photography. Sophie was the first member of her family to attend college and she chose The Annenberg School at the University of Southern California to study journalism and public relations, graduating magna cum laude with a BA in 2005. Her earliest exposure to art and artists included visits to galleries in Europe with her mother, which is where the abstract work of Picasso caught her eye and subconsciously imprinted an influence that would later become apparent in her own work. After graduating Sophie spent time working for her aunt at Apogee Electronics where she learned a number of skills that would help her later in her own business. Her love of writing, especially short stories, became an important and relevant aspect of her career. From 2013-15 she worked at The Society Club in London. It was during this time that she introduced sketching games to her dinner parties, which unlocked her love of art again after many years focusing on her writing. After moving back to LA Sophie began showing her work on social media and taking commissions. This eventually led to her decision to become a full time artist and since 2015 she has had her works shown in multiple solo and group gallery exhibitions and sold into commercial and private collections globally, including the Salam Art Collection in Iraq. Her writing was also gaining momentum and in 2017, her first book, The Optimist, a satirical look at the extremity of romantic desperation, was published by Unbound in the UK and later in the US and Canada in 2021. The novel was named a “Best Summer Read” by The Daily Mail and optioned for film and television adaptation. Sophie was also the subject of the Oscar-shortlisted short documentary, “Sophie and The Baron”, which chronicles Sophie's friendship and artistic collaboration with legendary Rolling Stone Magazine photographer Baron Wolman. The award-winning film, directed by Alexandria Jackson, premiered at SXSW Film Festival and was acquired by Disney as their first original documentary, and is now streaming worldwide on Disney Plus. Sophie lives and works in Santa Monica, CA. Sophie's links:https://www.sophiekipner.com/https://www.sophiekipner.com/bookhttps://www.imdb.com/title/tt13084870/https://www.instagram.com/skipner Some of Sophie's favorite female artists:Paula RegoAlice NeelKatherine BradfordCristina BanBanHilda PalafoxFrida KahloRobin F Williams Host: Chris StaffordProduced by Hollowell StudiosFollow @theaartpodcast on InstagramAART on FacebookEmail: theaartpodcast@gmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/wisp--4769409/support.

This week the American figurative abstract painter and writer Sophie Kipner who primarily uses the blind contouring technique. Sophie was born in Santa Monica in 1982 into an artistically musical family; her English mother Lizzie was a singer and dancer, her Australian father Steve, a songwriter, musician and producer, her grandfather, a songwriter and producer, and her brother Harrison, also a songwriter, musician and producer. Sophie however was to take a different route with an early interest in art, particularly sketching and learning portraiture, which would carry her through to her professional career.  Her parents emphasized self expression as a learning tool, encouraging her creativity. While attending Viewpoint High School in Calabasas she developed an interest in photography. Sophie was the first member of her family to attend college and she chose The Annenberg School at the University of Southern California to study journalism and public relations, graduating magna cum laude with a BA in 2005. Her earliest exposure to art and artists included visits to galleries in Europe with her mother, which is where the abstract work of Picasso caught her eye and subconsciously imprinted an influence that would later become apparent in her own work. After graduating Sophie spent time working for her aunt at Apogee Electronics where she learned a number of skills that would help her later in her own business. Her love of writing, especially short stories, became an important and relevant aspect of her career. From 2013-15 she worked at The Society Club in London. It was during this time that she introduced sketching games to her dinner parties, which unlocked her love of art again after many years focusing on her writing. After moving back to LA Sophie began showing her work on social media and taking commissions. This eventually led to her decision to become a full time artist and since 2015 she has had her works shown in multiple solo and group gallery exhibitions and sold into commercial and private collections globally, including the Salam Art Collection in Iraq. Her writing was also gaining momentum and in 2017, her first book, The Optimist, a satirical look at the extremity of romantic desperation, was published by Unbound in the UK and later in the US and Canada in 2021. The novel was named a “Best Summer Read” by The Daily Mail and optioned for film and television adaptation. Sophie was also the subject of the Oscar-shortlisted short documentary, “Sophie and The Baron”, which chronicles Sophie's friendship and artistic collaboration with legendary Rolling Stone Magazine photographer Baron Wolman. The award-winning film, directed by Alexandria Jackson, premiered at SXSW Film Festival and was acquired by Disney as their first original documentary, and is now streaming worldwide on Disney Plus. Sophie lives and works in Santa Monica, CA. Sophie's links:https://www.sophiekipner.com/https://www.sophiekipner.com/bookhttps://www.imdb.com/title/tt13084870/https://www.instagram.com/skipner Some of Sophie's favorite female artists:Paula RegoAlice NeelKatherine BradfordCristina BanBanHilda PalafoxFrida KahloRobin F Williams Host: Chris StaffordProduced by Hollowell StudiosFollow @theaartpodcast on InstagramAART on FacebookEmail: theaartpodcast@gmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/aart--5814675/support.

This week, Wes and Todd talk with Mixed Media Painter, Jessica Loving. Jessica discusses being an introvert, working large, growing up in Conifer, traveling around the world in her youth & how it plays into her work, her early engagement with art, James Turrell & Mark Rothko, her foundation in painting, her use of tulle, creative meditation, shamanism, the use of light or absence thereof in her work, divorce and the catalyst for her latest body of work, art as understanding of experience, her work being a visual poem, the materials that she incorporated into her latest exhibition, revealing & concealing, utilizing her wedding gown & ring in this new body of work, therapy, plant medicine, her experience with ayahuasca, her shamanic journey, the thought & experiences behind each piece in “unraveling/becoming, and looking to the future for a new body of work. Join us for a compelling conversation with Jessica Loving!Check out Jessica's work at her website – www.jessicaloving.com Follow Jessica on social media:Instagram - www.instagram.com/jessicalovingart/@jessicalovingartFacebook - www.facebook.com/StudioLovingExperience Jessica's exhibition, “unraveling/becoming”, at SeeSaw Art Gallery, currently on display through Sunday, October 19th, 2025 - www.seesawgallery.comSend us a text Follow us on Instagram: @tenetpodcast - www.instagram.com/tenetpodcast/ @wesbrn - www.instagram.com/wesbrn/ @toddpiersonphotography - www.instagram.com/toddpiersonphotography/ Follow us on Facebook: www.facebook.com/TenetPodcast/ Email us at todd@toddpierson.com If you enjoyed this episode or any of our previous episodes, please consider taking a moment and leaving us a review on your favorite podcast platform. Thanks for listening!

David CaryD.L. Cary | Faith-Fueled Suspense Novelist Unmasking Evil in The Veil ChroniclesD.L. Cary is a faith-fueled suspense novelist who detonates the boundaries of clean fiction.His breakout thriller Maria's Shadow thrusts readers into the perilous journey of a trafficked young mother who, less than two months pregnant, vows to outwit a powerful cabal to save her unborn son and expose their crimes.The danger escalates in The Veil Strikes—Book 2 of The Veil Chronicles—where a newly sanctioned, off-the-books task force assembles on a Texas ranch with a single mandate: root out the corruption strangling America's highest institutions, no matter the cost.Cary's work ignites high-octane action, redemptive faith, and razor-sharp social commentary into stories that leave readers breathless yet hopeful, proving that courage and conviction can still prevail over darkness.Want to be a guest on Book 101 Review? Send Daniel Lucas a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/17372807971394464fea5bae3 Hosted on Acast. See acast.com/privacy for more information.

Artist David Lloyd joins What's My Thesis? to reflect on a career that spans CalArts in the early 1980s, formative years at Margot Levin Gallery, and decades of navigating the shifting landscape of the Los Angeles art world. Known for his commitment to formalist abstraction, Lloyd discusses what it means to sustain a painting practice over forty years while adapting to the changing priorities of galleries, art fairs, and collectors. The conversation delves into his most recent body of work, where Lloyd integrates his own archive of paintings, drawings, and ceramics into AI image generation. By transforming these digital hallucinations into trompe l'oeil abstractions through resin, collage, and material experimentation, he considers how technology can challenge conventional definitions of painting while remaining rooted in physical process. Other topics include the legacy of CalArts conceptualism, the burdens of postmodern theory and art education, the precarity of mid-level galleries, and the paradox of elitism within the contemporary art market. Throughout, Lloyd emphasizes the importance of generosity, resilience, and longevity in sustaining a life in art. Listen for insights on: Abstract painting and formalist traditions in Los Angeles The role of AI in contemporary art practices The realities of the gallery system and art fairs Postmodernism, art education, and theory fatigue Building a career across decades in the art world

King Diamond "Haunted"Clipping with The Rita feat Benny The Butcher & El Camino "La Mala Ordina"Blue Sabbath Black Cheer "Salted Wound"DJ Screw "Situation On Dirty"Bathory "Noturnal Obeisance"Bathory "Massacre"Deathspell Omega "Drink The Devil's Blood"Lustmord "Heresy Part 6"Lil Ugly Mane "Cup Fulla Beetlejuice"Portal "Catafalque"Drudkh "Glare of Autumn"

Talking SANDchain, Pudgy Party hits 1 million installs, KGeN raises $13.5M and Proof of Play. [0:25] The big announcement is SANDchain; a Patreon-type rewards platform for creators.[1:25] It's more to do with providing extra utility for SAND token than for The Sandbox platform itself.[5:10] Verified creators can use SANDchain to take a loan to invest in their business.[7:01] Some creators will also be able to launch their own memecoins.[8:05] It feels like a smorgasbord of current blockchain trends. But will anyone actually use it?[9:44] Pudgy Party has hit 1 million mobile downloads and Mythos chain has also hit an ATH.[13:03] But the MYTH token is at a (near) ATL.[14:58] Web3 rewards platform KGeN has raised $13.5 million taking total funding to $43.5 million.[15:56] It started out as an Indian guild but is now a global platform with 66 million MAUs.[17:32] It verifies all its users across 5 categories, giving them an overall reputation score.[22:07] One thing to be aware of is KGeN's current users are being incentivized by a future airdrop.[24:29] South Korean web2/3 game item marketplace Overtake has launched its beta on Sui.[28:01] The continuing fall out from Pirate Nation's shutdown and the $50 burn price for its NFTs.33:10 Proof of Play is now working on a new mobile game.[34:53] It's also generated $500,000 in two months from its Proof of Play Arcade on Abstract.

The Conversion Code: Stop Chasing Leads and Start Attracting Clients The new edition of the bestselling book for real estate agents, loan officers, SaaS and small businesses. In this revision, The Conversion Code: A Step-by-Step Guide to Marketing and Sales that Will Grow Your Business Faster, Second Edition, digital marketing and lead conversion expert Chris Smith delivers the ultimate exploration of the marketing and advertising tactics that are successfully generating higher quality leads that are easier for salespeople to convert. Smith researches and tests the latest and most popular platforms, including TikTok, YouTube and Instagram, while also studying the most effective sales techniques, tools, and scripts.In this book, you'll learn to:Increase your lead conversion rate, reduce your cost per lead and improve your overall ROI from marketing and salesGenerate an endless supply of high-quality leads from social media that are easy to convert into closed salesStop chasing leads and start attracting clients with amazing marketing and clever adsAdapt to the consumer privacy changes that have made targeting ads and getting leads to answer the phone harder than everDifferentiate your brand in a way that positions you as the authority and gets people contacting you who are already soldAn invaluable reference and easy to follow guide for real estate agents, loan officers, SaaS and small businessescompeting in the hyper-competitive online environment. The Conversion Code, Second Edition, is also a fantastic resource for sales leaders, marketing managers, business owners and anyone else with a team who is responsible for growing revenue.Want to be a guest on Book 101 Review? Send Daniel Lucas a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/17372807971394464fea5bae3 Hosted on Acast. See acast.com/privacy for more information.

Tune in live every weekday Monday through Friday from 9:00 AM Eastern to 10:15 AM.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Buy our NFT⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our Discord⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check out our Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check out our YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠DISCLAIMER: The views shared on this show are the hosts' opinions only and should not be taken as financial advice. This content is for entertainment and informational purposes.

Featuring an interview with Dr Kevin Kalinsky, including the following topics: Patient-Reported Outcomes from the TROPION-Breast01 Study (0:00) Pernas S et al. Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Patient-reported outcomes from the TROPION-Breast01 study. ASCO 2024;Abstract 1006. Indirect Comparison of Sacituzumab Govitecan and Datopotamab Deruxtecan for Advanced Breast Cancer (5:04) Pathak N et al. Indirect comparison of sacituzumab govitecan (SG) and datopotamab deruxtecan (Dato-DXd) in advanced breast cancer (aBC): Safety and efficacy analysis. San Antonio Breast Cancer Symposium 2024;Abstract P1-02-02. BEGONIA: A Phase Ib/II Study of Datopotamab Deruxtecan with Durvalumab as First-Line Treatment for Unresectable Advanced Triple-Negative Breast Cancer (9:53) Schmid P et al. Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Updated results from BEGONIA, a phase Ib/II study. ESMO 2023;Abstract 379MO. Advances in the Use of TROP2-Targeted Antibody-Drug Conjugates for Breast Cancer: Mechanisms, Clinical Applications and Future Directions (15:35) Tong Y et al. Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: Mechanisms, clinical applications, and future directions. Front Immunol 2024;15:1495675. Abstract CME information and select publications

Unpacking the Korea crypto market with Pudgy Penguins and Abstract CEO Luca Netz. To get the show every week, follow the podcast ⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠. In today's Markets Outlook, Pudgy Penguins and Abstract CEO Luca Netz join CoinDesk's Jennifer Sanasie and Sam Ewen from Korea Blockchain Week to share his insights on why the country is the new epicenter of both global culture and crypto. He explains the staggering statistics on Korean crypto adoption, what American companies can learn from this market, and how his company, Abstract, is working to bring fun back to the EVM. This content should not be construed or relied upon as investment advice. It is for entertainment and general information purposes. - This episode was hosted by Jennifer Sanasie and Sam Ewen.

Unpacking the Korea crypto market with Pudgy Penguins and Abstract CEO Luca Netz. To get the show every week, follow the podcast ⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠. In today's Markets Outlook, Pudgy Penguins and Abstract CEO Luca Netz join CoinDesk's Jennifer Sanasie and Sam Ewen from Korea Blockchain Week to share his insights on why the country is the new epicenter of both global culture and crypto. He explains the staggering statistics on Korean crypto adoption, what American companies can learn from this market, and how his company, Abstract, is working to bring fun back to the EVM. This content should not be construed or relied upon as investment advice. It is for entertainment and general information purposes. - This episode was hosted by Jennifer Sanasie and Sam Ewen.

Abstract time and space sever our ties to place, rhythm, and responsibility! Or so argues the philosopher and ecologist, David Abram! 

Jon Jordan and Jenny Jordan talk through the week's news including:[0:44] This week, we asked our Mavens group about the rise of sustainable degen games.[2:00] Originally, this type of game was more about crypto than blockchain.[3:25] YGG is now calling this genre "casual degen" games.[4:40] These experiences start with a thin layer of gaming and a lot of high risk-high reward features.[7:30] You can often get 1,000 players into these games but how do you keep them [10:05] A lot of these games are launching on the Abstract blockchain.[13:00] Degen isn't a negative terms, at least not all the time.[13:25] Gigaverse has been going for 200 days, generating $5.5 million in revenue.[16:30] It's also building out its ecosystem with third party devs in the Gigaverse Hub.[19:39] YGG Play is publishing Gigachadbat on Abstract. [24:00] The Sandbox has announced Alpha 6 Season with Cirque du Soleil on 24th September.[27:45] The problem is The Sandbox hasn't got product-market-fit, esp. compared to Roblox.[29:55] It now needs to focus on creators, probably including the ability to launch tokens.[31:32] Off The Grid is starting to migrating EU-based PC players to the Gunz' mainnet.

In this episode of the Consumer Finance Monitor podcast, host Alan Kaplinsky welcomes Pat Utz, CEO and co-founder of Abstract, a venture capital-backed AI company headquartered in New York. Pat brings extensive expertise on artificial intelligence. The podcast focuses on current developments in AI regulation and implementation, first covering President Trump's recent "Winning the Race: America's AI Action Plan" and its potential impact on federal policy. Alan and Pat discuss the evolving landscape of AI statutes, and developments at the state-level in places like Utah and Colorado. Pat and Alan Kaplinsky provide insights into bipartisan efforts at both state and federal levels to address issues ranging from consumer safety to business innovation. They highlight the practical challenges and opportunities for businesses leveraging AI, such as the need for transparency when AI is used in customer interactions and compliance with state-level enforcement. Pat explains how open-source models are increasingly being promoted, pointing to Trump's executive order and shifts in the industry. He also underscores the importance for businesses to track where data is processed—whether with major vendors or proprietary systems—and adapt to varying regulatory frameworks, notably those set by states like California that tend to influence national practice. The episode concludes by focusing on the wide array of AI usage in financial services, specifically credit scoring and underwriting; lending; and fraud detection. Pat provides key lessons institutions should be mindful of as AI adoption continues to grow in the industry Consumer Finance Monitor is hosted by Alan Kaplinsky, Senior Counsel at Ballard Spahr, and the founder and former chair of the firm's Consumer Financial Services Group. We encourage listeners to subscribe to the podcast on their preferred platform for weekly insights into developments in the consumer finance industry.

Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in psychiatry. It is commonly prescribed for anxiety disorders, alcohol use disorder, and sometimes even bipolar disorder! But what does the evidence say?Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC3619699/#:~:text=The%20FDA%20approved%20gabapentin%20enacarbil,legs%20syndrome%20(RLS)%20symptoms.https://journals.lww.com/intclinpsychopharm/Abstract/2017/01000/Pregabalin_for_generalized_anxiety_disorder__an.8.aspxhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9507147/https://pmc.ncbi.nlm.nih.gov/articles/PMC4732322/https://pubmed.ncbi.nlm.nih.gov/9263379/https://pubmed.ncbi.nlm.nih.gov/28988943/https://www.cdc.gov/mmwr/volumes/71/wr/mm7119a3.htm

Cocteau Twins "When Mama Was Moth"Chelsea Wolfe "After The Fall"Jean-Claude Vannier "Mort Du Roi Des Mouches"Pestilence "Voices From Within"Pestilence "Spheres"Current 93 "To Blackened Earth"FKA Twigs "Ultraviolet"Arthur Russell "Tower Of Memory/Rabbit's Ear/Home Away From Home"Gert Thrue "I Play The Body Electronic"Anna Von Hausswolff "The Truth, The Glow, The Fall"Ozric Tentacles "Gnuthlia"Catherine Ribeiro + Alpes "L'ere De La Putrefaction"

Sometimes I want to become the character on my player board, living out their adventure and experiencing a dramatic story filled with excitement and suspense. Other times, I just want to move some wooden pieces across a plain board, while I am deep in thought, and a giant decision tree that's unfolding further with every turn fills my mind. Sometimes I yearn for a thematic experience, other times I crave something purely abstract. So in this article, I want to look at how these two board game categorisations shape the gameplay experience.Read the full topic discussion article here: https://tabletopgamesblog.com/2025/09/16/abstract-imagination-thematic-and-abstract-games-topic-discussion/Useful LinksBetrayal at House on the Hill review: https://tabletopgamesblog.com/2023/01/14/betrayal-at-house-on-the-hill-3rd-edition-saturday-review/Root review: https://tabletopgamesblog.com/2022/02/12/root-a-game-of-woodland-might-and-right-saturday-review/MusicIntro Music: Bomber (Sting) by Riot (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/audiolibrary/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠)Music: https://www.bensound.comLicense code: HAGPZN8QVBH9PRLBArtist: : Lunar YearsMusic by BensoundLicense code: C6OWWPO2VLQBAOCSArtist: : Theatre Of DelaysMusic I Use: https://www.bensound.com/free-music-for-videosLicense code: LRJMMDLS915XVZ4CArtist: : VitalMusic by https://www.bensound.comLicense code: RSJQEDEJQHLOGU0UArtist: : The FableSupportIf you want to support this podcast financially, please check out the links below:Ko-Fi: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://ko-fi.com/TabletopGamesBlog⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/tabletopgamesblog⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://tabletopgamesblog.com/support/⁠⁠⁠⁠⁠⁠(Photo by Bruno Ramos Lara on Unsplash)

What does it mean to truly experience God's grace? In 2 Corinthians 6, Paul warns us not to let grace remain abstract but to live it out urgently and distinctly—now is the day of salvation, and we are God's holy …

In this episode of the Dementia Researcher podcast, host Adam Smith discusses the upcoming AAIC Neuroscience Next Conference with guests Tricia Nicholson, Dr Amanda Heslgrave, and Kalli Mavromati. They explore the unique hybrid format of the conference, which combines in-person and virtual elements, making it accessible to a global audience. The conversation highlights the focus on biomarkers in dementia research, the importance of early career researchers, and the abstract submission process, providing valuable tips for potential presenters. The episode emphasizes the conference's goal of fostering collaboration and sharing knowledge within the dementia research community. -- Takeaways: • The AAIC Neuroscience Next Conference is free and accessible to all. Taking place across 6 countries and online from the 23rd to 26th February 2026. • The UK hub will focus on biomarker advancements in dementia diagnosis, with a full in-person conference on the 26th February. • The conference aims to support early career researchers in dementia research. • A unique hybrid format allows for both in-person and virtual participation. • Abstract submissions open on September 22nd and are encouraged from all researchers. From basic science to dementia care. • The UK Hub is particularly keen for researchers to submit abstract in biomarker domains. o Fluid Biomarkers o Cognitive Assessments o Physiological and Behavioural Biomarkers o Neuroimaging o Technology Biomarkers -- For more information on the global event visit: https://www.alz.org/neurosciencenext/overview.asp For information on the UK Hub visit: https://www.dementiaresearcher.nihr.ac.uk/aaic-neuroscience-next-2026-manchester-uk/ -- Find more information on our guests, and a full transcript of this podcast on our website at: https://www.dementiaresearcher.nihr.ac.uk/podcast -- The views and opinions expressed by guests in this podcast represent those of the guests and do not necessarily reflect those of NIHR Dementia Researchers, PIA membership, ISTAART or the Alzheimer's Association. -- Follow us on social media: https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/ https://www.twitter.com/demrescommunity https://www.linkedin.com/company/dementia-researcher https://www.bsky.app/profile/dementiare…archer.bsky.social -- Download and Register with our Community App: https://www.onelink.to/dementiaresearcher

Featuring an interview with Dr Jacob Sands, including the following topics: Management of Adverse Events of Special Interest Associated with Datopotamab Deruxtecan (Dato-DXd) (0:00) Heist RS et al. Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan. Cancer Treat Rev 2024;125:102720. Abstract  Sands J et al. Analysis of drug-related interstitial lung disease (ILD) in patients (pts) treated with datopotamab deruxtecan (Dato-DXd). ASCO 2024;Abstract 8623. Intracranial Efficacy of Dato-DXd for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations in the TROPION-Lung05 Study (7:23) Lisberg A et al. Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05. ASCO 2024;Abstract 8593.  Clinical Evidence Supporting the Combination of Dato-DXd with Immune Checkpoint Inhibition for Advanced NSCLC (12:12) Bessede A et al. TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer. Clin Cancer Res 2024;30(4):779-85. Abstract Levy BP et al. TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC). ASCO 2025;Abstract 8501. Waqar SN et al. First-line (1L) datopotamab deruxtecan (Dato-DXd) + rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5). ASCO 2025;Abstract 8521. Current and Future Development of Antibody-Drug Conjugates in the Treatment of Lung Cancer (17:11) Tawfiq RK et al. Targeting lung cancer with precision: The ADC therapeutic revolution. Curr Oncol Rep 2025;27(6):669-86. Abstract CME information and select publications

This week, Wes and Todd talk with Abstract Watercolorist, Tiffani Erdmanczyk. Tiffani discusses her earliest art memory, thinking outside the box, creativity, being an Architect, living in Seattle, moving to Colorado, her favorite Architects, exploring watercolor, being an Abstract Watercolorist, having sensory neuropathy, using salt in her watercolors, process, comfort & chaos, creating 8100 color patches, watercolor properties, teaching water color, texture, mentors, taking classes & workshops, group shows, getting into the headspace to create, NKollectiv, favorite Artists, pricing, commissions, her current exhibition “Drift”, Chat GPT, water, and balance over perfection.Join us for an illuminating and delightful conversation with Tiffani Erdmanczyk!Check out Tiffani's exquisite work at her website - www.tiffanierdmanczykart.comFollow Tiffani on social media:Instagram - www.instagram.com/tiffanierdmanczykart/ - @tiffanierdmanczykartFacebook - www.facebook.com/tiffanierdmanczykartCheck out Tiffani's exhibition, “Drift”, with Carol Till, at NKollectiv gallery, on display through September 28th, 2025 - www.nkollectiv.comSign up for Tiffani's Watercolor 101 class, Saturday, September 27th, at NKollectiv  - www.tiffanierdmanczykart.com/watercolor-101/watercolor-101Send us a text Follow us on Instagram: @tenetpodcast - www.instagram.com/tenetpodcast/ @wesbrn - www.instagram.com/wesbrn/ @toddpiersonphotography - www.instagram.com/toddpiersonphotography/ Follow us on Facebook: www.facebook.com/TenetPodcast/ Email us at todd@toddpierson.com If you enjoyed this episode or any of our previous episodes, please consider taking a moment and leaving us a review on your favorite podcast platform. Thanks for listening!

Columbus Ohio based bassplayer, songwriter, and producer shares his amazing background and passion for music in the style that only Steve Perakis can deliver: Abstract and entertaining. Many shoutouts pepper his music adventures that are shared in his words and arrangement. This episode is available wherever you listen to your podcasts. More information on Steve Perakis and his music can be found here: https://www.woodensoul.com/

Behavioral finance is often viewed as abstract but it can be a powerful, practical tool for helping clients make better decisions and build lives that align with what matters most. This episode explores how applying behavioral insights and positive psychology can deepen client relationships and drive more meaningful planning conversations. Dr. Daniel Crosby is the Chief Behavioral Officer at Orion, a technology platform serving financial advisors. Listen in as Daniel shares how he's turned complex behavioral concepts into usable advisor tools, including a “money personality” framework and a flourishing goals assessment. We talk about why understanding where clients fall on five key money dimensions - like communication style or spending vs. saving - can help reduce judgment and improve client outcomes, and how identifying gaps between what clients value and how they feel they're doing in life can spark more relevant financial goals. Daniel also reflects on why advisors must examine their own money beliefs and blind spots, and how practicing nonjudgmental listening may be the most powerful behavioral tool of all. For show notes and more visit: https://www.kitces.com/454

Episode Resources:WOCNext Abstract DetailsAbstract Author ResourcesePoster InformationPrevious Accepted AbstractsAbstracts in JWOCN® Online SupplementInterested in an abstract mentor? Email abstracts@wocn.orgAbout the Speaker:Donna Bliss, PhD, RN, FGSA, FAAN, WOCNF, is a Professor, Chair of the Adult and Gerontological Health Cooperative, and School of Nursing Foundation Professor of Nursing Research at the University of Minnesota School of Nursing, Minneapolis, MN. She has 25 years of funded research and 125+ publications and presentations about assessing, preventing, and managing fecal incontinence and incontinence associated skin damage. She is a forerunner in investigating disparities in skin damage and assessing dark skin. Donna is an active member of the WOCN® Society and is the 202-2026 WOCNext® Abstract Chair. During the WOCNext 2023 event, Donna was awarded the Barbara Braden Future is Bright Award and was also inducted into the inaugural class of the WOCN Fellow Program.Editing and post-production work for this episode was provided by The Podcast Consultant.

What if AI could decode government in real time? In this episode of Eye on AI, Craig Smith sits down with Pat Utz, CEO and Co-Founder of Abstract, the AI startup building “regulatory superintelligence” to track and analyze laws, bills, and regulations across 145,000+ government entities. Pat explains how Abstract evolved from university research into a venture-backed company helping law firms, enterprises, and policymakers cut through the noise of Congress, state legislatures, and regulatory agencies. From uncovering hidden amendments in massive bills to proactively identifying risks and opportunities for businesses, Abstract is transforming how we understand legislation. We cover: How AI is reshaping lobbying, law, and compliance Why Abstract is focused on proactive intelligence, not reactive compliance The role of AI agents, LLMs, and retrieval-augmented generation (RAG) in policy analysis Real examples of AI influencing funding and legislation The future of democracy when citizens and businesses have true transparency into government Whether you're in tech, law, government affairs, or just curious about how AI is changing democracy, this conversation reveals the future of policy intelligence.

We've got Olskool Ice-Gre and E.P. the Hellcat AKA Abstract Mindstate joining us to talk about their new album with Young RJ of Slum Village called “The Art Project”. We'll hear about the process of creating the album, their approach to addressing a new generation of rappers and much more. Then we have an energetic discussion about their album pick for this episode - “One For All” by Brand Nubian, which includes a never before told story about Abstract Mindstate opening a show for Grand Puba and 2Pac at Tougaloo College in the early '90s.Purchase "The Art Project" here:https://abstractmindstate.bandcamp.com/album/the-art-project

Featuring an interview with Dr Erika Hamilton, including the following topics: Monitoring, mitigating and managing adverse events with antibody-drug conjugates (ADCs) for breast cancer (0:00) Heist RS et al. Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan. Cancer Treat Rev 2024;125:102720. Abstract Management protocols for adverse events associated with sacituzumab govitecan (7:49) García JMP et al. Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in patients with triple-negative or HR+/HER2- advanced breast cancer (ABC; PRIMED): A phase 2 trial. ASCO 2024;Abstract 1101. Pérez-García JM et al. Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): An open-label, single-arm, phase 2 trial. eClinicalMedicine 2025;85:103309. Abstract Datopotamab deruxtecan for patients with breast cancer brain metastases or leptomeningeal disease (10:51) Tarantino P et al. DATO-Base: A phase II study of DATOpotamab deruxtecan for patients with breast cancer brain metastases or leptomeningeal disease. ASCO 2025;Abstract TPS1134. Sequencing ADCs in breast cancer (13:12) Pacholczak-Madej R et al. Sequencing of antibody drug conjugates in breast cancer: Evidence gap and future directions. Biochim Biophys Acta Rev Cancer 2025;[Online ahead of print]. Abstract CME information and select publications

Tyler The Creator "I'll Take Care of You"Earl Sweatshirt "Heavy Metal AKA Ejecto Seato"Stereolab "Flashes From Everywhere"Oklou "Blade Bird"Flume & JPEGMAFIA "The Ocean is Fake"Mark Pritchard & Thom Yorke "The White Cliffs"SUMAC & Moor Mother "Scene 4"Panda Bear "Left In The Cold"Melvins "Venus Blood"Eartheater & Shygirl "Shark Brain"Deerhoof "Disobedience" Kara-Lis Coverdale "Problem of No Name"Legendary Pink Dots "Sleight of Hand"

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

Matthew takes us on a spiritual journey through his curious resistance to Zen's boundless acceptance. Is acceptance a hindrance to growth and change? Do we ultimately fear the contentment we seek? Does our Zen have room for both aimlessness and agency?? Find out here!

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

This week's episode of Consensus is the most jam packed yet!We cover:- Are we in the first 5 year cycle, are cycles over, or are we about to enter a bear market?- BTC & ETH ATH's and the rest of the market- Is retail going where we all hope they go?- Big players building their own chains instead of your fav L1s- Forgotten Playland Season ending & what you need to know- RemixGG's OpenSea jam sees insane metrics- Wildcard's Road to Dreamhack updates- Project O teases mobile version- Off the Grid's new Content Pack- Moonray launches iOS version of their game- Spellborne's expansion to Abstract and Ronin-inspired monsters- RavenQuest's expansion and economy changes- Game7's latest announcement & a reflection on ecosystems- duper announced DuperBowl- Castle of Blackwater goes FTP & targets mainstream- MaplestoryU's latest monthly update & huge revenue numbers- ReplyCorp airdrop and what you need to do- Shrapnel raises more money, good or bad for the space?- Immutable Play opens to Web2 games, bullish or nah?- DroegeDaniel's list of radio silent gamesThis and more, all in one episode! Listen and tell us what you think!As always, nothing we say is financial advice.

In this episode of Behind the Knife, Dr. Patrick Georgoff sits down with Dr. Keri Seymour and Dr. Joey Lew to tackle the complex world of gastrostomy tubes. What may seem like a routine and straightforward procedure is anything but—full of nuanced patient considerations, timing dilemmas, technical challenges, and potential complications that can turn a “simple” consult into a 2 a.m. call you won't forget. From who truly needs a G tube and when to managing difficult post-op issues like dislodgement and buried bumper syndrome, this episode breaks down the practical, evidence-based approach every surgeon should know. Whether you're managing stroke patients, trauma cases, or navigating the tricky administrative obstacles around enteral access, this episode will equip you with the insights and strategies to confidently dominate your G tube consults. Hosts:  ·      Dr. Patrick Georgoff (Acute Care Surgeon, Duke University) ·      Dr. Keri Seymour (Minimally Invasive & Acute Care Surgeon, Duke Regional) ·      Dr. Joey Lew (Surgical Resident, BTK MIS Team) Learning Goals: By the end of this episode, listeners will be able to:  ·      Understand the nuanced indications for gastrostomy tube (G tube) placement. ·      Learn which patients truly benefit from G tubes, and when enteral access is not appropriate or indicated. ·      Appreciate the importance of goals of care discussions, assessment of comorbidities, and decision-makers—especially in neurocritical and elderly populations. ·      Know evidence-based timing for gastrostomy tube placement in stroke, TBI, and other complex scenarios. ·      Understand guideline recommendations and the clinical reasoning behind trial periods of nasogastric feeding versus early G tube placement. ·      Describe technical approaches to G tube placement and how to tailor the method to patient anatomy and clinical context. ·      Solidify knowledge of when to choose endoscopic, laparoscopic, open, or interventional radiology-guided placement. ·      Recognize, manage, and strive to prevent common and serious complications of G tubes, including early and late dislodgement, buried bumper syndrome, infection, bleeding, and gastrocutaneous fistula. ·      Discuss perioperative considerations, including anticoagulation, patient stability, and post-procedural care. ·      Understand why routine suturing of the G tube or bumper is not recommended, and how administrative and facility factors can drive clinical decisions. ·      Gain practical pearls and quick decision trees to dominate G tube consults and troubleshooting, day or night. References: ·      Braun R, Han K, Arata J, Gourab K, Hearn J, Gonzalez-Fernandez M. Establishing a clinical care pathway to expedite rehabilitation transitions for stroke patients with dysphagia and enteral feeding needs. Am J Phys Med Rehabil. 2024;103(5):390-394. doi:10.1097/PHM.0000000000002387 https://pubmed.ncbi.nlm.nih.gov/36867953/ ·      Burgermaster M, Slattery E, Islam N, Ippolito PR, Seres DS. Regional comparison of enteral nutrition-related admission policies in skilled nursing facilities. Nutr Clin Pract. 2016;31(3):342-348. doi:10.1177/0884533616629636 https://pubmed.ncbi.nlm.nih.gov/26993318/ ·      Chaudhry R, Kukreja N, Tse A, Pednekar G, Mouchli A, Young L, Didyuk O, Wegner RC, Grewal N, Williams GW. Trends and outcomes of early versus late percutaneous endoscopic gastrostomy placement in patients with traumatic brain injury: Nationwide population-based study. J Neurosurg Anesthesiol. 2018;30(3):251-257. doi:10.1097/ANA.0000000000000434 https://pubmed.ncbi.nlm.nih.gov/28459729/ ·      Cleverdon SA, Costantini TW, McGrew TM, Santorelli JE, Berndtson AE, Haines LN. Dysphagia in patients with traumatic brain injury, how often do they really need feeding access? Presented at: Academic Surgical Congress; February 2025; Washington, DC. Abstract 92.33. ·      Cmorej P, Mayuiers M, Sugawa C. Management of early PEG tube dislodgement: simultaneous endoscopic closure of gastric wall defect and PEG replacement. BMJ Case Rep. 2019;12(9):e230728. doi:10.1136/bcr-2019-230728 https://pubmed.ncbi.nlm.nih.gov/31488448/ ·      Galovic M, Stauber AJ, Leisi N, et al. Development and validation of a prognostic model of swallowing recovery and enteral tube feeding after ischemic stroke. JAMA Neurol. 2019;76(5):561-570. doi:10.1001/jamaneurol.2018.4858 https://pubmed.ncbi.nlm.nih.gov/30742198/ ·      Gallo RJ, Wang JE, Madill ES. Things we do for no reason™. J Hosp Med. 2024;19(8):728-730. doi:10.1002/jhm.13263 https://pubmed.ncbi.nlm.nih.gov/38180160/ ·      George BP, Hwang DY, Albert GP, Kelly AG, Holloway RG. Timing of percutaneous endoscopic gastrostomy for acute ischemic stroke. Stroke. 2017;48(2):420-427. doi:10.1161/STROKEAHA.116.015119 https://pubmed.ncbi.nlm.nih.gov/27965430/ ·      Goldberg LS, Altman KW. The role of gastrostomy tube placement in advanced dementia with dysphagia: a critical review. Clin Interv Aging. 2014;9:1733-1739. doi:10.2147/CIA.S53153 https://pubmed.ncbi.nlm.nih.gov/25342891/ ·      Hartford A, Li W, Qureshi D, et al. Use of feeding tubes among hospitalized older adults with dementia. JAMA Netw Open. 2025;8(2):e2460780. doi:10.1001/jamanetworkopen.2024.60780 https://pubmed.ncbi.nlm.nih.gov/39976967/ ·      Hochu G, Soule S, Lenart E, Howley IW, Filiberto D, Byerly S. Synchronous tracheostomy and gastrostomy placement results in shorter length of stay in traumatic brain injury patients. Am J Surg. 2024;227:153-156. doi:10.1016/j.amjsurg.2023.10.012 https://pubmed.ncbi.nlm.nih.gov/37852846/ ·      Kobzeva-Herzog AJ, Nofal MR, Bodde J, et al. Implementation of a quality improvement initiative reduced adult inpatient gastrostomy tube dislodgements. Am J Surg. 2025;(article 116522). doi:10.1016/j.amjsurg.2025.116522 https://pubmed.ncbi.nlm.nih.gov/40782502/ ·      Kurt Boeykens, Ivo Duysburgh. Prevention and management of major complications in percutaneous endoscopic gastrostomy. BMJ Open Gastroenterol. 2021;8:e000628. https://pubmed.ncbi.nlm.nih.gov/33947711/ ·      Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia. Arch Intern Med. 2003;163(11):1351-1353. doi:10.1001/archinte.163.11.1351 https://pubmed.ncbi.nlm.nih.gov/12796072/ ·      Papavramidis TS, Mantzoukis K, Michalopoulos N. Confronting gastrocutaneous fistulas. Ann Gastroenterol. 2011;24(1):16-19. https://pubmed.ncbi.nlm.nih.gov/24714282/ ·      Rajan A, Wangrattanapranee P, Kessler J, Kidambi TD, Tabibian JH. Gastrostomy tubes: fundamentals, periprocedural considerations, and best practices. World J Gastrointest Surg. 2022;14(4):286-303. doi:10.4240/wjgs.v14.i4.286 https://pubmed.ncbi.nlm.nih.gov/35664365/ ·      Reddy KM, Lee P, Gor PJ, Cheesman A, Al-Hammadi N, Westrich DJ, Taylor J. Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes. World J Gastrointest Pharmacol Ther. 2022;13(5):77-87. doi:10.4292/wjgpt.v13.i5.77 https://pubmed.ncbi.nlm.nih.gov/36157266/ ·      Singh D, Laya AS, Vaidya OU, Ahmed SA, Bonham AJ, Clarkston WK. Risk of bleeding after percutaneous endoscopic gastrostomy (PEG). Dig Dis Sci. 2012;57(4):973-980. doi:10.1007/s10620-011-1965-7 https://pubmed.ncbi.nlm.nih.gov/22138961/ ·      Thosani N, Rashtak S, Kannadath BS, et al. Bleeding risk and mortality associated with uninterrupted antithrombotic therapy during percutaneous endoscopic gastrostomy tube placement. Am J Gastroenterol. 2021;116(9):1868-1875. doi:10.14309/ajg.0000000000001348 https://pubmed.ncbi.nlm.nih.gov/34158462/ ·      Ward EC, Green K, Morton AL. Patterns and predictors of swallowing resolution following adult traumatic brain injury. J Head Trauma Rehabil. 2007;22(3):184-191. doi:10.1097/01.HTR.0000271119.96780.f5 https://pubmed.ncbi.nlm.nih.gov/17510594/ ·      Wick B. Timing of PEG tube placement in stroke patients with dysphagia: a multi-center retrospective cohort analysis using the TriNetX database. Am J Gastroenterol. 2024;119(10 Suppl):S1146-S1147. doi:10.14309/01.ajg.0001035684.98119.d5 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen BTK Fan Favorites:  General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

Background Music for Sleep, Meditation, Relaxation, Massage, Yoga, Studying and Therapy - Deep Energy 2132 -2134 - Angels in the Abstract - Parts 1 - 3 AD FREE VERSIONS OF ALL THE PODCASTS ARE HERE: www.jimbutler.bandcamp.com …… Please remember to turn on automatic downloads, like and subscribe, tell a friend, share with your family and leave a review. All of those things help build the podcast. Thank you so much!! ………. This podcast is ad supported. We try the best we can to keep all of the ads at the front and the back of the podcast, but depending on the length of the podcast, there maybe ads in the middle. Please check my Bandcamp page for ad free podcasts. www.jimbutler.bandcamp.com ……………………….. Watch me play live on TikTok @jimbutlermusic or On the Insight Timer App as Jim Butler Links for all of the podcasts in the Deep Energy Podcast Network: Deep Energy Podcast (Current Episodes) https://podcasts.apple.com/us/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga/id511265415 https://open.spotify.com/show/1DhN56DzDKc0FhQqR23v9c Deep Energy Classics - All of the ORIGINAL Episodes  https://podcasts.apple.com/us/podcast/deep-energy-classics-original-episodes/id1734274408 https://www.spreaker.com/podcast/deep-energy-classics-original-episodes--6108618 https://open.spotify.com/show/7BjEFnqcyKWUkHcYdtFS25?si=05aeab39b5bc4a00 Deep Energy Daily Affirmations - Daily Affirmations to get you through the day https://podcasts.apple.com/us/podcast/deep-energy-daily-affirmations/id1729162791 https://open.spotify.com/show/0oaA8dRsWDQLkqeXmykGvu?si=461c7b47417b4e55 Deep Energy Guided Meditations - Guided Meditations to help through your day https://podcasts.apple.com/us/podcast/deep-energy-guided-meditations-with-michelle-davis-jim/id1732674561 https://open.spotify.com/show/1Kg2LTaFux10Ul94phybp8?si=ebbbf33757d64c13 https://www.spreaker.com/podcast/deep-energy-guided-meditations-with-michelle-davis-jim-butler--6098026 Slow Piano for Sleep - Solo Piano Pieces https://podcasts.apple.com/us/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and/id1626828397 https://www.spreaker.com/podcast/slow-piano-for-sleep-music-for-sleep-meditation-and-relaxation--5572963 ………… www,jimbutlermusic.com jimbutlermusic@gmail.com All Social Media (FB - IG - YT - TT) is: @jimbutlermusic Merch: www.deepenergy.threadless.com Bandcamp Monthly No Ads Subscription/Patreon: www.jimbutler.bandcamp.com Custom Made Music: jimbutlermusic@gmail.com ………………….. Thank you for listening. All music is created, performed and composed by Jim Butler. AI IS NEVER USED TO CREATE MY MUSIC. Until the next time, please be kind to one another, peace, bye… …….. Original Image by the Dream App (not sponsored) or Canva (not sponsored) …………………. Become a supporter of this podcast: https://www.spreaker.com/podcast/deep-energy-podcast-music-for-sleep-meditation-yoga-background-music-and-studying--4262945/support.

A track for a movie about drawing blood at 3 am in a hospital. Abstract poetry to say the least. Begins as [Instrumental], then words. [Lyrics] Where you live Where you go And yet you're not conscious anymore Up in the snow turning to water like a fish you avoid the surface Finding the truth Aligning with doubt You must shout I am not you.

Dark ObsessionPrepare yourself for a whirlwind journey through the highs and lows of life in Dark Obsession. India Ward seems to have it all by society's standards, but her personal life is unraveling beneath the surface. When faced with the realization that she merely exists rather than truly living, India must confront the pivotal choices that could alter her destiny forever.This compelling novella delves into themes of love, self-discovery, and resilience. As India navigates her tumultuous world, she encounters Mykell Hope—a suave, intelligent man who understands the game of life and its intricate rules. Together, they explore the delicate balance between heart and mind, teaching us profound lessons about life and love along the way.Dark Obsession is more than a story; it's a reflection on the complexities of the human experience, urging readers to embrace the transformative power of choice and authenticity. Dive in and discover what it truly means to live. Hosted on Acast. See acast.com/privacy for more information.

Can estranged family relationships actually be repaired? Drawing from research on reconciliation, Whitney outlines the five core ingredients necessary for genuine repair - active empathetic listening, accountability, behavioral change, mutual willingness, and safety. Whitney distinguishes between genuine repair efforts and surface-level compliance, explains when relationships are likely unsalvageable, and provides practical guidance for assessing whether reconciliation is truly possible or if it's time to accept the relationship's limitations. Whitney Goodman is a Licensed Marriage and Family Therapist (LMFT) and the founder of Calling Home, a membership community that helps people navigate complex family dynamics and break harmful cycles. Join the Family Cyclebreakers Club⁠⁠ Follow Whitney on Instagram | sitwithwhit Follow Whitney on YouTube | @whitneygoodmanlmft ⁠⁠Order Whitney's book, Toxic Positivity⁠⁠ This podcast is for informational purposes only and is not a substitute for professional mental health advice. 03:42 The Five Core Ingredients of Family Repair 13:09 When Relationships Are Unsalvageable 23:05 Genuine Repair vs Surface-Level Compliance 28:33 Assessing Capacity for Change https://callinghome.co/topics/family-estrangement/how-to-begin-reconciliation-with-an-estranged-family-member https://callinghome.co/topics/family-estrangement/should-we-be-estranged-checklist  https://callinghome.co/topics/accepting-your-parents/i-m-estranged-from-my-dying-parent-should-i-reconnect-and-help-them  [1] Kelley, D. L., Waldron, V. R., & Kloeber, D. N. (2019). A Communicative Approach to Conflict, Forgiveness, and Reconciliation. Routledge. https://www.routledge.com/A-Communicative-Approach-to-Conflict-Forgiveness-and-Reconciliation-Reimagining-Our-Relationships/Kelley-Waldron-Kloeber/p/book/9781138052666?srsltid=AfmBOoq4iGgtwMAvbAv4-FKP9EOORNLadpnlRmmGIY_rXYPEvirm7Ymr  [2] Tomm, K. (2002). Enabling Forgiveness and Reconciliation in Family Therapy. The International Journal of Narrative Therapy and Community Work. https://dulwichcentre.com.au/wp-content/uploads/2016/12/13-KarlT2.pdf  [3] Blood, P. (2012). The Repair and Restoration of Relationships. In Springer eBook (pp. 349-370). https://link.springer.com/chapter/10.1007/978-94-007-2147-0_17  [4] vanOyen Witvliet, C., Root Luna, L. M., Worthington, E. L., & Tsang, J. (2020). Apology and Restitution: The Psychophysiology of Forgiveness After Accountable Relational Repair Responses. Frontiers in Psychology, 11. https://journals.sagepub.com/doi/abs/10.1177/0091647120915181#:~:text=Abstract,promoting%20their%20empathy%20and%20forgiveness.  [5] Fishbane, M. D. (2019). Healing Intergenerational Wounds: An Integrative Relational–Neurobiological Approach. Family Process, 59(3), 1043-1063. https://pubmed.ncbi.nlm.nih.gov/31518458/  [6] De Mol, J., Lemmens, G., Verhofstadt, L., & Kuczynski, L. (2013). Intergenerational transmission in a bidirectional context. Psychologica Belgica, 53(3), 7–23. https://doi.org/10.5334/pb-53-3-7  [8] Byng-Hall, J. (2008). The significance of children fulfilling parental roles: implications for family therapy. Journal of Family Therapy, 30(2), 147-162. https://doi.org/10.1111/j.1467-6427.2008.00423.x[9] Paleari, F. G., Tagliabue, S., & Lanz, M. (2011). Empathic Perspective Taking in Family Relationships: A Social Relations Analysis. https://www.researchgate.net/publication/236587449_Empathic_Perspective_Taking_in_Family_Relationships_A_Social_Relations_Analysis Learn more about your ad choices. Visit podcastchoices.com/adchoices

✨ **Grab my Creative Direction template for FREE** ✨Curious what the first stage of my brand design projects looks like? Grab the Figma template (and four bonus audio trainings walking you through how to populate it!) below! I'll send it out September 1, 2025 (or automatically after that date) - are you ready?

My guest today is Ramtin Naimi. Ramtin is the founder of Abstract Ventures, one of the most talked-about seed funds in Silicon Valley. What makes Ramtin's story so compelling isn't just his firm's remarkable track record—including early investments in Rippling, Solana, and dozens of unicorns—but also the unconventional path he took to get there. From running a hedge fund straight out of high school to filing for bankruptcy at 24, then bootstrapping his way to building a $2 billion AUM venture firm using AngelList and relentless hustle. Our conversation begins in an unexpected place—the art world—where Ramtin has become a sophisticated collector, learning from mentors like Michael Ovitz about market dynamics that surprisingly mirror venture capital. We dive deep into how the art world actually works, and Ramtin explains how these lessons about "masterpieces" apply directly to identifying power-law companies in venture. We go deep on his approach to early-stage investing and how he built Abstract as a co-investment vehicle alongside firms like Sequoia, Benchmark, and Andreessen Horowitz. We explore his portfolio construction model, his philosophy on dilution-sensitive founders, and why he takes upwards of 30 pitch meetings per week to build his "frame of reference." We discuss why Abstract has the highest graduation rate from seed to Series A among all seed funds, and how this competitive advantage compounds over time. This is his first time telling his story, and we discuss the power of pattern recognition, relentless work ethic, and the unique opportunities available to those willing to start from scratch in Silicon Valley. Please enjoy this great conversation with Ramtin Naimi. Colossus Review Profile: Ramtin Naimi For the full show notes, transcript, and links to mentioned content, check out the episode page⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠here⁠⁠.⁠⁠⁠⁠⁠⁠⁠⁠ ----- This episode is brought to you by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Ramp⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Ramp's mission is to help companies manage their spend in a way that reduces expenses and frees up time for teams to work on more valuable projects. Go to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Ramp.com/invest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to sign up for free and get a $250 welcome bonus. – This episode is brought to you by⁠⁠⁠⁠⁠⁠ AlphaSense⁠⁠⁠⁠⁠⁠. AlphaSense has completely transformed the research process with cutting-edge AI technology and a vast collection of top-tier, reliable business content. Invest Like the Best listeners can get a free trial now at⁠⁠⁠⁠⁠⁠ Alpha-Sense.com/Invest⁠⁠⁠⁠⁠⁠ and experience firsthand how AlphaSense and Tegus help you make smarter decisions faster. – This episode is brought to you by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Ridgeline⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Ridgeline has built a complete, real-time, modern operating system for investment managers. It handles trading, portfolio management, compliance, customer reporting, and much more through an all-in-one real-time cloud platform. Head to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ridgelineapps.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to learn more about the platform. ----- Editing and post-production work for this episode was provided by The Podcast Consultant (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thepodcastconsultant.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠). Show Notes: (00:00:00) Welcome to Invest Like the Best (00:05:40) Learning from Mentors and Starting to Collect (00:08:50) Parallels Between Art and Venture Capital (00:12:57) Challenges in Art Collecting (00:20:45) The Role of Status in the Art World (00:25:00) Who Makes the Most Money in the Art World? (00:28:19) Abstract Ventures: Early Stage Investing (00:42:34) Starting a Venture Capital Firm from Scratch (00:43:12) Overcoming Bankruptcy and Early Struggles (00:50:34) Evaluating Technical Capabilities and Momentum (01:02:53) Competing for Deals and Building Relationships (01:15:25) The Role of Brand in Venture Capital (01:22:39) Early Life and Entrepreneurial Beginnings (01:28:40) Starting a Hedge Fund and Learning Hard Lessons (01:31:26) Transition to Venture Capital (01:37:19) Building Abstract and Family Life (01:52:03) The Kindest Thing Anyone Has Done For Ramtin

During our summer break, we are re-airing some of our favorite episodes. What do you do when hope feels lost? Abstract artist Lanecia Rouse Tinsley is no stranger to the hopelessness that comes with grief. In extended isolation because of the pandemic, a nationwide reckoning with race, and our own personal losses, we could all use a bit of what Lanecia calls holy seeing. In this episode, Kate and Lanecia discuss how creativity can be an act of resistance and the hope she discovered on a blank canvas. CW: Miscarriage, death of a child, racism Watch clips from this conversation, read the full transcript, and access discussion questions by clicking here or visiting katebowler.com/podcasts. Follow Kate on Instagram, Facebook, or X (formerly known as Twitter)—@katecbowler. Links to social pages and more available at linktr.ee/katecbowler.See omnystudio.com/listener for privacy information.